Virginia Regulatory Town Hall
Department of Medical Assistance Services
Board of Medical Assistance Services
Methods and Standards for Establishing Payment Rate; Other Types of Care [12 VAC 30 ‑ 80]
MAC Reimbursement for Specialty Drugs
Action 2649
General Information
Action Summary Specialty pharmaceuticals represent the fastest growing segment of the prescription drug market in the U.S. Industry projections have the growth rate at 20% per year. Typically, these products are used to treat chronic and/or rare diseases, are high-cost, and can be administered by injection, infusion inhalation, or orally. DMAS is promulgating this regulation in an effort to help contain the costs of these complex and expensive drugs.
Chapters Affected Only affects this chapter.
Executive Branch Review This action will go through the normal Executive Branch Review process.
RIS Project Yes  [001319]
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
4618 Emergency/NOIRA Stage complete. Emergency regulation superseded by final permanent regulation.
4875 Proposed Stage complete. Comment period ended 08/07/2009.
5273 Final Stage complete. This regulation became effective on 12/23/2009.
Contact Information
Name / Title: Keith Hayashi  / Health Care Services Division -- Pharmacy
Address: 600 East Broad Street
Suite 1300
Richmond, VA 23219
Email Address:
Phone: (804)225-2773    FAX: (804)786-1680    TDD: ()-